Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Name: Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
Published: 2020
License: Public Domain

Baylor College of Medicine · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

chronic myeloid leukemia, chronic myeloid leukemia, bcr/abl-positive, in remission, chronic myeloid leukemia in remission, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

Related documents